Shares of The Clorox Company (NYSE:CLX – Get Free Report) have been assigned an average rating of “Reduce” from the fourteen research firms that are currently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and one has issued a buy recommendation on the company. The average 12 month target price among analysts that have covered the stock in the last year is $155.38.
Several equities analysts have recently issued reports on CLX shares. JPMorgan Chase & Co. upped their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and raised their target price for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Evercore ISI dropped their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. StockNews.com raised shares of Clorox from a “hold” rating to a “buy” rating in a research note on Saturday, December 28th. Finally, DA Davidson upped their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research report on Monday, November 4th.
Read Our Latest Stock Analysis on Clorox
Clorox Trading Up 0.7 %
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.49 earnings per share. As a group, equities analysts anticipate that Clorox will post 6.85 earnings per share for the current fiscal year.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.00%. Clorox’s payout ratio is 170.03%.
Hedge Funds Weigh In On Clorox
Several institutional investors have recently modified their holdings of the business. Prospera Private Wealth LLC acquired a new stake in Clorox during the 3rd quarter worth approximately $27,000. Trifecta Capital Advisors LLC increased its position in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after acquiring an additional 130 shares in the last quarter. Continuum Advisory LLC raised its holdings in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the period. Quarry LP lifted its position in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares in the last quarter. Finally, Carolina Wealth Advisors LLC acquired a new position in Clorox in the 3rd quarter worth $48,000. Institutional investors own 78.53% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- What Investors Need to Know About Upcoming IPOs
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Investing In Automotive Stocks
- Nebius Group: The Rising Star in AI Infrastructure
- How to Calculate Stock Profit
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.